Parexel names former INC Research exec as CEO, will ex Syneos CFO follow?
Parexel names former INC Research executive Jamie Macdonald as its new CEO – with discussion that Gregory Rush will follow after his early departure from Syneos.
Archives for March 5, 2018
News in Brief
CDMO BioDuro acquires Molecular Response
BioDuro has acquired Molecular Response LLC and its translational oncology research platform, which includes a biobank of more than 100,000 viable tumor specimens.
EMA post-Brexit update: Completion day set, building approval on track
Dutch authorities say the EMA’s permanent headquarters will be completed by November 15, 2019 – more than seven months after the agency’s relocation deadline.
GSK taps Covance for clinical trials tech
LabCorp’s Covance Drug Development business has entered into a strategic technology agreement with GlaxoSmithKline plc (GSK) through which the company will use several of the CRO’s software solutions.
Bracket partners with Uber Health to ease clinical trial site, patient burden
Uber has selected Bracket as a launch partner for its new healthcare offering which aims to expedite patient transportation – an oft-cited barrier to clinical trial participation.
US FDA track and trace: Industry welcomes data standardisation
The US FDA’s latest guidance is a positive step towards data integrity in the supply chain, says serialisation firm SEA Vision.
Aurobindo injectables plant receives Form 483 with nine observations
The US FDA has issued a Form 483 to a manufacturing plant in Hyderabad, India but Aurobindo says none of the observations relate to data integrity.